SYRE
Spyre Therapeutics, Inc.Company with tickers: SYRE
CIK
1636282
CUSIP
00773J202
Shares Outstanding
86,841,253
13F Activity (30d)
153 filings
151 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-03 | SHELDON SLOAN | Officer | 16,667 | 2026-06-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-08 | MICHAEL HENDERSON | Director | 80,000 | 2026-05-08 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-01 | SCOTT BURROWS | Officer | 27,500 | 2026-05-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-01 | SHELDON SLOAN | Officer | 78,333 | 2026-05-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-04-01 | SHELDON SLOAN | Officer | 7,958 | 2026-04-01 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-03 | SCOTT BURROWS | Officer | 10,000 | 2026-03-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-02 | CAMERON TURTLE | Director, Officer | 60,000 | 2026-03-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-11-03 | CAMERON TURTLE | Director, Officer | 90,000 | 2025-11-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-10-25 | SESSIONS, LLC | Director | 7,000 | 2024-10-25 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Showing 1–9 of 9 filings